High Percentage of Patients Seek Mental Health Care from PCPs, According to New Large Analysis
September 23, 2024

One in 9 primary care encounters involved a mental health condition, according to an analysis of over 350 million primary care visits.

COVID-19 Vaccines 2024-2025: Is America Ready and Willing?
September 23, 2024

COVID-19 vaccine myths of many types remain potent enough to raise public health experts' concerns about Americans' willingness to roll up sleeves this year.

Real-World Study Supports Use of DermaSensor in Primary Care to Differentiate Cancerous and Benign Lesions
September 23, 2024

The AI-based point-of-care device outperformed clinician standard of care for sensitivity (90% vs 40%) and had a negative predictive value of 98.9%

September Issue of Patient Care Online Supplement is Now Live
September 23, 2024

Find details on advances in the management of type 1 diabetes, utilization of CGM in primary care settings, and optimizing T2D management in older persons.

More than One-Third of US Adults Say They "Don't Need" Respiratory Virus Vaccines this Fall
September 23, 2024

Adults saying they don't need immunization this fall have received the vaccines in the past, survey authors report, suggesting a lingering misinformation effect.

RSV Vaccine Effective Against Hospitalization in Older Adults: Daily Dose
September 23, 2024

Your daily dose of the clinical news you may have missed.

Erenumab Induces Remission in Chronic Migraine Medication Overuse Headache
September 20, 2024

Erenumab 140 mg safely and effectively induced remission in nonopioid MOH within 6 months in individuals for whom other preventive medications had failed.

First Self-Administered Flu Vaccine Approved by US FDA
September 20, 2024

FluMist is the first influenza vaccine that does not have to be given by a health care professional.

First-Ever CGM Cleared for 365-Day Use
September 20, 2024

The only CGM system cleared for 1 year of use in type 1 and 2 diabetes is expected to be available in the fourth quarter of this year, the manufacturers said.

ACIP Highlights Evidence Supporting Recommendation for PCV21 Vaccine for Adults
September 20, 2024

New report includes data on the safety and immunogenicity of the recently-approved PCV21 vaccine.